Back to results
US 7,351,718 B2Granted
Substituted pyrrolidine and related compounds
AssigneeTheravance, Inc.
InventorsMathai Mammen, Adam Hughes, Yu-hua Ji, Li Li, Weijiang Zhang
Life of this patent
Estimating the term…
Abstract
This invention is directed to compounds of formula I: wherein R1-R5 and a-e are as defined in the specification; or pharmaceutically-acceptable salt or solvate or stereoisomer thereof. The invention also directed to pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors using such compounds.
Claims12
A compound of formula X:
- wherein
- P is an amino-protecting group;
- each R1 and R2 is independently selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, cyano, halo, —ORa, —SRa, —S(O)Ra, —S(O)2Ra and —NRbRc;
- or two adjacent R1 groups or two adjacent R2 groups are joined to form C3-6 alkylene, —(C2-4 alkylene)-O— or —O—(C1-4 alkylene)-O—;
- each R3 is independently selected from C1-4 alkyl and fluoro;
- each R4 is independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C6-10 aryl, C2-9 heteroaryl, C3-6 heterocyclic, —CH2—R6 and —CH2CH2—R7;
- or both R4 groups are joined together with the nitrogen atom to which they are attached to form C3-6 heterocyclic;
- R5 is selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, and —CH2—R8;
- wherein each alkyl, alkenyl, alkynyl and cycloalkyl group is optionally substituted with —OH or 1 to 3 fluoro substituents;
- each R6 is independently selected from C3-6 cycloalkyl, C6-10 aryl, C2-9 heteroaryl and C3-6 heterocyclic;
- each R7 is independently selected from C3-6 cycloalkyl, C6-10 aryl, C2-9 heteroaryl, C3-6 heterocyclic, —OH, —O(C1-6 alkyl), —O(C3-6 cycloalkyl), —O(C6-10 aryl), —O(C2-9 heteroaryl), —S(C1-6 alkyl), —S(O)(C1-6 alkyl), —S(O)2(C1-6 alkyl), —S(C3-6 cycloalkyl), —S(O)(C3-6 cycloalkyl), —S(O)2(C3-6 cycloalkyl), —S(C6-10 aryl), —S(O)(C6-10 aryl), —S(O)2(C6-10 aryl), —S(C2-9 heteroaryl), —S(O)(C2-9 heteroaryl) and —S(O)2(C2-9 heteroaryl);
- each R8 is independently selected from C3-6 cycloalkyl, C6-10 aryl, C2-9 heteroaryl and C3-6 heterocyclic;
- each Ra is independently selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl and C3-6 cycloalkyl;
- each Rb and Rc is independently selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl and C3-6 cycloalkyl;
- or Rb and Rc are joined together with the nitrogen atom to which they are attached to form C3-6 heterocyclic;
- a is an integer from 0 to 3;
- b is an integer from 0 to 3;
- c is an integer from 0 to 4;
- d is 1 or 2;
- and
- e is 8 or 9;
- wherein each alkyl, alkylene, alkenyl, alkynyl and cycloalkyl group in R1, R2, R3, R4, R7, Ra, Rb and Rc is optionally substituted with 1 to 5 fluoro substituents;
- each aryl, cycloalkyl, heteroaryl and heterocyclic group in R1, R2, R4, R5, R6, R7, R8, Ra, Rb and Rc is optionally substituted with 1 to 3 substituents independently selected from C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, cyano, halo, —O(C1-4 alkyl), —S(C1-4 alkyl), —S(O)(C1-4 alkyl), —S(O)2(C1-4 alkyl), —NH2, —NH(C1-4 alkyl) and —N(C1-4 alkyl)2, wherein each alkyl, alkenyl and alkynyl group is optionally substituted with 1 to 5 fluoro substituents;
- and each —CH2— group in —(CH2)e— is optionally substituted with 1 or 2 substituents independently selected from C1-2 alkyl, —OH and fluoro;
- or a salt or solvate or stereoisomer thereof.
22 more elements
Dependencies are inferred from the claim text.